Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)

(2009) Frederick G. Kushner et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial

(2009)   LANCET

Prime time for a polypill after myocardial infarction?

(2009) Valentin Fuster   Nature clinical practice. Cardiovascular medicine

Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998 to 2006

(2008) Gregg C. Fonarow et al.   AMERICAN HEART JOURNAL

The European Heart Journal: parting thoughts after 6 years of editorship

(2008) F. Van de Werf   EUROPEAN HEART JOURNAL

Fixed-dose combination therapy and secondary cardiovascular prevention: rationale, selection of drugs and target population

(2008) Ginés Sanz et al.   Nature clinical practice. Cardiovascular medicine